期刊文献+

丹参酮ⅡA对H9c2心肌细胞缺血再灌注损伤的保护机制 被引量:5

Mechaniam of the protective effect of Tanshinone ⅡA on myocardial ischemia-reperfusion injury
下载PDF
导出
摘要 目的观察丹参酮ⅡA对心肌缺血再灌注损伤的保护作用及相关信号传导通路。方法通过建立H9c2心肌细胞缺血再灌注模型,分别加入不同浓度丹参酮ⅡA,采用CCK-8检测细胞存活率,通过流式细胞术检测细胞凋亡率;另外分为丹参酮ⅡA组、AG490组、丹参酮ⅡA及AG490组,通过Western blot方法检测JAK2、P-JAK2、STAT3、P-STAT3蛋白表达。结果 CCK-8检测显示模型组细胞存活率为78.90%±5.163%,与对照组比较,差异有统计学意义(P<0.05);丹参酮ⅡA 2.5μM组细胞存活率为85.76%±6.101%,与模型组比较,P>0.05;丹参酮ⅡA 10μM组细胞存活率为90.62%±2.321%,与模型组比较,P<0.05;丹参酮ⅡA 40μM组细胞存活率为86.38%±4.712%,与模型组比,P<0.05;流式细胞术检测显示加入丹参酮ⅡA缺血再灌注导致的心肌细胞凋亡数减少;丹参酮ⅡA组P-JAK2、P-STAT3蛋白表达较缺血再灌注组明显上升,而AG490组的P-JAK2蛋白表达明显下调。结论丹参酮ⅡA可改善缺血再灌注引起的大鼠心肌细胞凋亡,其保护机制可能与JAK2/STAT3信号通路有关。 Objective To study the protective effect of tanshinone ⅡA on myocardial ischemia-reperfution(I/R) injury and related signialing pathway. Methods Made H9c2 myocytes I/R models, add different concentrations of tanshinone ⅡA after 24 hours, then test apoptosis rate by cck-8 and flow cytometry. Add tanshinone ⅡA, AG490, tanshinone ⅡA+AG490 respectively, then assay the expression of JAK2, P-JAK2, STAT3, P-STAT3 by western blot. Results CCK-8tests showed the cell survival rate of model group was 78.90%±5.163%, compared with the control group had statistical differences. Compared with the model group, the cell survival rate increased to 85.76% ±6.101% at the tanshinone ⅡA concentration of 2.5 μM(P0.05), increased to 90.62%±2.321% at the tanshinone ⅡA concentration of 10 μM(P0.05), and increased to 86.38%±4.712% at the tanshinone ⅡA concentration of 40 μM(P0.05). Flow cytometry analysis also displayed tanshinone ⅡA could decrease the number of myocardial apoptosis which caused by I/R injury. The expression of P-JAK2 and P-STAT3 increased in tanshinone ⅡA group compared to I/R group. The expression of PJAK2 reduced in AG490 group. Conclusion Tanshinone ⅡA can reduce I/R induced myocardial apoptosis, and the protective mechanism may be related to the JAK2-STAT3 signaling pathway.
出处 《中国现代医生》 2014年第33期1-3,8,共4页 China Modern Doctor
基金 浙江省自然科学基金资助项目(LY13H150009)
关键词 丹参酮ⅡA H9C2心肌细胞 缺血再灌注 JAK2/STAT3信号通路 Tanshinone ⅡA H9c2 cells Ischemia-reperfusion JAK2-STAT3 signaling pathway
  • 相关文献

参考文献13

  • 1Mendis S,Puska P,Norrving B. Global atlas on cardiovas cular disease prevention and control[M]. Geneva:The World Health Organization, 2011 : 4.
  • 2Zhang Y,Wei L,Sun D,et al. Tanshinone IIA pretreat- ment protects myocardium against ischaemia/repeffusion injury through the phosphatidylinositol 3-kinase/Akt-de- pendent pathway in diabetic rats[J]. Diabetes Obes Metab. 2010,12(4) :316-322.
  • 3Chanoit G,Lee S,Xi J,et al. Exogenous zinc protects car- diac cells from reperfusion injury by targeting mitochon- drial permeability transition pore through inactivation of glycogen synthase kinase-3beta[J]. Am J Physiol Heart Circ Physiol, 2008,295 (3) : H 1227-H 1233.
  • 4翟昌林,黎莉,张运.丹皮酚对大鼠心肌缺血再灌注损伤保护中HMGB1表达的影响[J].中华中医药学刊,2012,30(10):2284-2286. 被引量:11
  • 5何治,潘志红,鲁文红.丹参酮IIA对局灶性脑缺血大鼠的神经保护作用及其机制初探[J].中药药理与临床,2009,25(5):32-34. 被引量:9
  • 6Ma XJ,Zhang XH,Li CM,et al. Effect of postconditioning on coronary blood flow velocity and endothelial function inpatients with acute myocardial infarction[J]. Scand Cardio- vasc J,2006; 40(6):327-333.
  • 7Seidel HM,Lamb P,Rosen J. Pharmaceutical intervention in the JAK/STAT signaling pathway[J]. Oncogene,2000,19 (21) :2645-2656.
  • 8Waiters AM,Porter GA Jr,Brookes PS. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy[J]. Circ Res, 2012,111 (9) : 1222-1236.
  • 9Kubli DA, Gustafsson AB. Mitochondria and mitophagy: The yin and yang of cell death control[J]. Circ Res,2012, 111 (9) :1208-1221.
  • 10Ziegelhoffer A,Mujkosova J,Ferko M,et al. Dual influ- ence of spontaneous hypertension on membrane proper- ties and ATP Droduction in heart and kidney mitochon-dria in rat:Effect of captopril andnifedipine,adaptation and dysadaptation[J]. Can J Physiol Pharmacol, 2012,90 (9) : 1311-1323.

二级参考文献20

  • 1钟先阳,罗仁,魏华,谢潮鑫,薛松.丹参酮ⅡA对大鼠出血性休克再灌注肾损伤的保护作用[J].中国中西医结合杂志,2002,22(S1):114-116. 被引量:4
  • 2王蓉,曾晓荣,王贞,李景新,谢冬萍,刘克敬,陈连璧.丹参酮ⅡA磺酸钠对家兔缺血预处理心肌保护作用的影响[J].微循环技术杂志(临床与实验),2004,8(5):335-335. 被引量:18
  • 3Han JY, Fan JY, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injuu by ischemia and reperfusion. Pharmacol Ther, 2008,117 (2): 280-295.
  • 4Yu XY, Lin SG, Zhou ZW, et al. Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuroprotective activity in experimentally stroked rats. Nenrosci Lett, 2007 ,417 (3) : 261 - 265.
  • 5Zea LEL, Weinstein PR, Carlson S. Reversible middle cerebral artery occlusion without crainietomy in rats. Stroke, 1989, 20(6): 84-91.
  • 6He Z, Liao Y, Zheng M, et al. Piracetam Improves Cognitive Deficits Caused by Chronic Cerebral Hypopeffusion in Rats. Cell Mol Neurobiol, 2008, (28): 613-627.
  • 7Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol, 2005, 75(3): 207-46.
  • 8Nelson RM, lambert DG, Green A. Pharmacology of ischemia-induced glutamate efflux from rat cerebral cortex in vitro. Brain Res, 2003 ,964 (4):1-8.
  • 9Durukan A, Tatlisumak T. Acute ischemic stroke : Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav, 2007,87(8): 179-197.
  • 10Maczewki M, Beresewicz A, Schwartz M, et al. The role of endo- thelin, protein kinase C and radicals in the mechanism of the pos- tischemic endothelial dysfunction in guineapig hearts [ J ]. Mol Cardiol,2000,32 (2) :297 -310.

共引文献17

同被引文献92

引证文献5

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部